Tempus AI (TEM) | Financial Analysis & Statements
Tempus AI Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
367.2M
Gross Profit
237.7M
64.73%
Operating Income
-61.4M
-16.72%
Net Income
-54.2M
-14.75%
Balance Sheet Metrics
Total Assets
2.3B
Total Liabilities
1.8B
Shareholders Equity
491.3M
Debt to Equity
3.63
Cash Flow Metrics
Operating Cash Flow
-28.1M
Free Cash Flow
-43.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Tempus AI Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 693.4M | 531.8M | 320.7M | 257.9M |
| Cost of Goods Sold | 473.9M | 312.3M | 245.6M | 190.5M | 174.2M |
| Gross Profit | 797.9M | 381.1M | 286.2M | 130.2M | 83.6M |
| Gross Margin % | 62.7% | 55.0% | 53.8% | 40.6% | 32.4% |
| Operating Expenses | |||||
| Research & Development | 319.0M | 316.8M | 185.5M | 162.3M | 128.4M |
| Selling, General & Administrative | 715.4M | 755.4M | 296.8M | 233.4M | 199.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.0B | 1.1B | 482.3M | 395.6M | 327.4M |
| Operating Income | -252.9M | -691.1M | -196.1M | -265.4M | -243.7M |
| Operating Margin % | -19.9% | -99.7% | -36.9% | -82.8% | -94.5% |
| Non-Operating Items | |||||
| Interest Income | 12.6M | 11.1M | 7.6M | 3.0M | 623.0K |
| Interest Expense | 70.3M | 53.7M | 46.9M | 21.9M | 15.2M |
| Other Non-Operating Income | 19.4M | 32.3M | 21.8M | -4.8M | -316.0K |
| Pre-tax Income | -291.1M | -701.3M | -213.5M | -289.2M | -258.6M |
| Income Tax | -51.7M | 266.0K | 288.0K | 66.0K | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -245.0M | -705.8M | -214.1M | -289.8M | -259.2M |
| Net Margin % | -19.3% | -101.8% | -40.3% | -90.4% | -100.5% |
| Key Metrics | |||||
| EBITDA | -106.5M | -610.4M | -133.3M | -236.8M | -219.5M |
| EPS (Basic) | $-1.41 | $-6.23 | $-1.61 | $-2.08 | $-1.85 |
| EPS (Diluted) | $-1.41 | $-6.23 | $-1.61 | $-2.08 | $-1.85 |
| Basic Shares Outstanding | 174264000 | 119849000 | 164832610 | 160708000 | 160708000 |
| Diluted Shares Outstanding | 174264000 | 119849000 | 164832610 | 160708000 | 160708000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Tempus AI Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 604.8M | 341.0M | 165.8M | 302.9M | 277.7M |
| Short-term Investments | 150.2M | 107.3M | 31.8M | 0 | - |
| Accounts Receivable | 311.2M | 154.8M | 94.5M | 88.7M | 82.2M |
| Inventory | 51.7M | 38.4M | 28.8M | 22.3M | 22.9M |
| Other Current Assets | 40.5M | 26.1M | 17.3M | 19.4M | 17.3M |
| Total Current Assets | 1.2B | 667.6M | 350.3M | 438.6M | 404.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 208.1M | 124.8M | 112.2M | 89.0M | 47.8M |
| Goodwill | 1.3B | 158.4M | 168.6M | 143.5M | 69.3M |
| Intangible Assets | 355.3M | 11.7M | 21.9M | 37.3M | 37.3M |
| Long-term Investments | - | 0 | 26.4M | 24.9M | 31.1M |
| Other Non-Current Assets | 58.2M | 9.2M | 9.8M | 9.6M | 7.6M |
| Total Non-Current Assets | 1.1B | 258.5M | 213.7M | 192.7M | 127.4M |
| Total Assets | 2.3B | 926.1M | 564.1M | 631.4M | 531.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 82.0M | 53.8M | 54.4M | 46.0M | 33.8M |
| Short-term Debt | 13.4M | 6.5M | 6.4M | 6.4M | 419.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 8.7M | 7.0M | 8.2M | 2.4M | 8.0M |
| Total Current Liabilities | 372.4M | 291.1M | 232.6M | 174.2M | 114.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.3B | 461.6M | 481.7M | 426.7M | 238.5M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 56.6M | 16.0M | 19.8M | 9.6M | - |
| Total Non-Current Liabilities | 1.4B | 578.7M | 1.7B | 1.6B | 1.2B |
| Total Liabilities | 1.8B | 869.8M | 1.9B | 1.8B | 1.3B |
| Equity | |||||
| Common Stock | 18.0K | 17.0K | 6.0K | 6.0K | 6.0K |
| Retained Earnings | -2.4B | -2.2B | -1.4B | -1.1B | -807.5M |
| Treasury Stock | 6.6M | 3.6M | 3.6M | 0 | 0 |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 491.3M | 56.3M | -1.4B | -1.1B | -807.5M |
| Key Metrics | |||||
| Total Debt | 1.3B | 468.1M | 488.1M | 433.0M | 238.9M |
| Working Capital | 794.8M | 376.5M | 117.7M | 264.4M | 289.2M |
Balance Sheet Composition
Tempus AI Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -245.0M | -705.8M | -214.1M | -289.8M | -259.2M |
| Depreciation & Amortization | 102.3M | 37.2M | 33.3M | 30.4M | 23.9M |
| Stock-Based Compensation | 124.7M | 534.1M | 0 | 0 | 559.0K |
| Working Capital Changes | -181.2M | -84.8M | -76.7M | 40.5M | -3.5M |
| Operating Cash Flow | -226.2M | -197.4M | -240.6M | -210.7M | -230.9M |
| Investing Activities | |||||
| Capital Expenditures | -21.0M | -22.1M | -34.6M | -18.4M | -11.8M |
| Acquisitions | -376.7M | -95.2M | -5.7M | -39.6M | -6.0M |
| Investment Purchases | -2.7M | -36.2M | 0 | 0 | - |
| Investment Sales | 8.3M | 23.1M | 0 | 0 | - |
| Investing Cash Flow | -392.1M | -130.4M | -40.3M | -57.9M | -21.7M |
| Financing Activities | |||||
| Share Repurchases | -3.0M | -2.2M | -3.6M | 0 | 0 |
| Dividends Paid | 0 | -5.6M | -5.6M | -5.6M | -5.6M |
| Debt Issuance | 1.0B | 0 | 82.9M | 170.6M | 0 |
| Debt Repayment | -284.7M | 0 | -288.0K | -375.0K | -796.0K |
| Financing Cash Flow | 884.1M | 494.3M | 117.5M | 251.4M | -2.0M |
| Free Cash Flow | -245.4M | -211.2M | -248.9M | -186.6M | -223.8M |
| Net Change in Cash | 265.8M | 166.6M | -163.3M | -17.2M | -254.7M |
Cash Flow Trend
Tempus AI Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
39.30
Forward P/E
-576.48
Price to Book
18.89
Price to Sales
7.35
PEG Ratio
-576.48
Profitability Ratios
Profit Margin
-19.27%
Operating Margin
-16.70%
Return on Equity
-89.48%
Return on Assets
-9.66%
Financial Health
Current Ratio
3.13
Debt to Equity
270.11
Per Share Data
EPS (TTM)
$-1.41
Book Value per Share
$2.76
Revenue per Share
$7.30
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TEM | 9.4B | 39.30 | 18.89 | -89.48% | -19.27% | 270.11 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| BrightSpring Health | 9.3B | 100.33 | 5.24 | 5.92% | 1.48% | 143.60 |
| HealthEquity | 6.6B | 31.61 | 3.14 | 10.19% | 16.39% | 47.53 |
| Waystar Holding | 4.8B | 40.74 | 1.23 | 3.22% | 10.20% | 38.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.






